ICCA accounts for 10–15% of primary liver cancers and is notorious for late-stage diagnosis and resistance to chemotherapy ...

ICCA accounts for 10–15% of primary liver cancers and is notorious for late-stage diagnosis and resistance to chemotherapy ...

ICCA accounts for 10–15% of primary liver cancers and is notorious for late-stage diagnosis and resistance to chemotherapy ...

CD56, and CD29) and fluorescence-activated cell sorting (FACS) to isolate CD31 − /CD45 − /CD29 + /CD56 + MuSCs. Although this method initially achieved an 85% PAX7-positive cell population ...

The revised version of the current manuscript is solid now. It's very interesting that there is bi-potential ability of human CD29/CD56+ myogenic progenitors. The current study substantiates the ...

The tumors in these mice showed high expression of cancer stem cell markers CD56 and CD20, suggesting a role for mutant vimentin in driving cancer stem cell-like behaviour that is often associated ...

The CD3-CD16+CD56+ natural killer absolute count was 96.7±28.7 (lower limit of normal=138), increasing to 163±57.2 with disease resolution in three patients. The fourth patient was followed elsewhere.

We find that CD56/CD90/CD24 co‐expression labels ENS cells with higher specificity and resolution than previous methods. Surprisingly, neuronal (CD24, TUBB3) and glial (SOX10) selective markers appear ...

The following is a summary of “Analysis of CD4, CD8, CD19, CD56-16, CD64, QuantiFERON biomarkers in exudative lymphocyte-dominant pleural effusion,” published in the November 2022 issue of Primary ...